hydrocortisone-17-butyrate has been researched along with Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marks, R; Mills, CM | 1 |
| Wagner, BM; Young, JM; Yoxall, BE | 1 |
| Holm, P; Serup, J | 1 |
1 review(s) available for hydrocortisone-17-butyrate and Atrophy
| Article | Year |
|---|---|
Side effects of topical glucocorticoids.
Topics: Administration, Cutaneous; Adult; Atrophy; Betamethasone Valerate; Biopsy; Cell Count; Clobetasol; Drug Evaluation; Female; Glucocorticoids; Humans; Hydrocortisone; Keratinocytes; Male; Middle Aged; Occlusive Dressings; Pharmaceutical Vehicles; Prednisolone; Skin; Telangiectasis; Ultrasonography | 1993 |
1 trial(s) available for hydrocortisone-17-butyrate and Atrophy
| Article | Year |
|---|---|
Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Atrophy; Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Clobetasol; Dermatologic Agents; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Pregnadienes; Random Allocation; Skin; Telangiectasis; Ultrasonography | 1985 |
1 other study(ies) available for hydrocortisone-17-butyrate and Atrophy
| Article | Year |
|---|---|
Corticosteroid-induced dermal atrophy in the rat.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Atrophy; Betamethasone; Desonide; Dexamethasone; Hydrocortisone; Male; Rats; Skin; Triamcinolone Acetonide | 1977 |